U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 3
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935 or
Section 30(f) of the Investment Company Act of 1940
(Print or Type Responses)
================================================================================
1. Name and Address of Reporting Person*
Johnson & Johnson
One Johnson & Johnson Plaza
New Brunswick, New Jersey 08933
LIB Acquisition Corp.
c/o Johnson & Johnson
One Johnson & Johnson Plaza
New Brunswick, New Jersey 08933
- --------------------------------------------------------------------------------
================================================================================
2. Date of Event Requiring Statement (Month/Day/Year)
7/21/98
================================================================================
3. IRS or Social Security Number of Reporting Person (Voluntary)
22-01024240
================================================================================
4. Issuer Name and Ticker or Trading Symbol
DePuy, Inc. (DPU)
================================================================================
5. Relationship of Reporting Person to Issuer
(Check all applicable)
[ ] Director [ X ] 10% Owner
[ ] Officer (give title below) [ ] Other (specify below)
--------------------------------------------------------------------
================================================================================
6. If Amendment, Date of Original (Month/Year)
================================================================================
7. Individual or Joint/Group Filing (Check applicable line)
[ ] Form Filed by One Reporting Person
[ X ] Form Filed by More than One Reporting Person
================================================================================
Table I -- Non-Derivative Securities Beneficially Owned
================================================================================
<TABLE>
<CAPTION>
3. Ownership Form:
2. Amount of Securities Direct (D) or
1. Title of Security Beneficially Owned Indirect (I) 4. Nature of Indirect Beneficial Ownership
(Instr. 4) (Instr. 4) (Instr. 5) (Instr.5)
- ------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C>
Common Stock, 83,000,000 I See note on attached page.
par value $.01
per share
- ------------------------------------------------------------------------------------------------------------------------------------
====================================================================================================================================
</TABLE>
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
* If the Form is filed by more than one Reporting Person, see Instruction
5(b)(v)
Page 1 of 2
<PAGE>
FORM 3 (continued)
Table II -- Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
================================================================================
<TABLE>
<CAPTION>
5. Owner-
3. Title and Amount of Securities ship
Underlying Derivative Security Form of
2. Date Exercisable (Instr. 4) Derivative
and Expiration Date --------------------------------- 4. Conver- Security:
(Month/Day/Year) Amount sion or Direct 6. Nature of
---------------------- or Exercise (D) or Indirect
Date Expira- Number Price of Indirect Beneficial
1. Title of Derivative Exer- tion of Derivative (I) Ownership
Security (Instr. 4) cisable Date Title Shares Security (Instr.5) (Instr. 5)
- ------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C>
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
====================================================================================================================================
</TABLE>
Explanation of Responses:
On July 21, 1998, in connection with the proposed merger (the "Merger") of
LIB Acquisition Corp. (the "Purchaser"), a wholly owned subsidiary of Johnson &
Johnson ("Parent"), with and into DePuy, Inc., the Purchaser and Parent have
entered into a Stockholder Agreement (the "Stockholder Agreement") with certain
stockholders (the "Stockholders") of DePuy, Inc., which are indirect wholly
owned subsidiaries of Roche Holding Ltd. In the Stockholder Agreement, the
Stockholders have agreed with Parent and the Purchaser to tender to the
Purchaser, pursuant to the Purchaser's tender offer (the "Offer") for all the
outstanding shares of common stock, par value $.01 per share, of DePuy, Inc.
(the "Shares"), all the Shares owned by them representing an aggregate of
83,000,000 Shares, or approximately 84.0% of the Shares outstanding as of July
21, 1998, at a price of $35 per share. In addition, any Shares that any such
Stockholder may subsequently acquire (by exercise of stock options or otherwise)
automatically become subject to the provisions of the Stockholder Agreement. If
the Purchaser accepts for payment and pays for any Shares tendered under the
Offer, the Purchaser must exercise such purchase option immediately following
the Offer (unless all the Shares subject to the Stockholder Agreement have been
tendered by the Stockholders and accepted for payment by the Purchaser under the
Offer). Pursuant to the Stockholder Agreement, each Stockholder has also
delivered a proxy to the Purchaser to vote, or grant a consent or approval in
respect of, the Shares subject to the Stockholder Agreement against any
transaction with a third party other than the transactions contemplated by the
Offer and the Merger.
/s/ PETER S. GALLOWAY 7/30/98
- --------------------------------------------- -----------------------
**Signature of Reporting Person Date
Johnson & Johnson
By: Peter S. Galloway
Title: Secretary
/s/ JAMES R. HILTON 7/30/98
- --------------------------------------------- -----------------------
**Signature of Reporting Person Date
LIB Acquisition Corp.
By: James R. Hilton
Title: Vice President
** Intentional misstatements or omissions of facts constitute Federal Criminal
Violations.
See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed.
If space provided is insufficient. See Instruction 6 for procedure.
Potential persons who are to respond to the collection of information contained
in this form are not required to respond unless the form displays a currently
valid OMB Number.
Page 2 of 2
